AzTrials
AzTrials

HIV-related StigmaNCT04946071

Reducing HIV-related Stigma in School Children in Northern Uganda

A study testing Arts-based HIV stigma intervention in people with HIV-related Stigma and Health Risk Behaviors, run by Thompson Rivers University at 1 site in Uganda.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Over 2.6 million children aged 0-15 years are living with HIV globally, with the majority living in low and middle income countries in sub-Saharan Africa. Addressing stigma associated with HIV is key given the significant harm that may be experienced in the form of negative health and social outcomes, reduced access… Read more about this study

Who is it for?
Ages 10 years and older
What is being tested?
Arts-based HIV stigma intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
2,900 participants
Where
1 siteUganda
Study dates
5 May 2021to 6 Jan 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 10 years and older
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Children (age ≥10 years) in Omoro District, Northern Uganda
  • Attending a government-funded primary and/or secondary school in the Omoro District
  • Enrolled in primary grades 4-6 and secondary grades 1-3

Who cannot join

  • Does not meet one or more inclusion criteria
  • Those attending the following government-funded schools due to distance: Awere secondary school, Awere primary school, Dino primary school, Odek primary school, Agweno primary school, Jing Komi primary school, Acet primary school, Awali primary school, Aromo Wanglobo primary school, Binya primary school

Trial locations and contacts

1 site in 1 country.

Uganda1 site
  • Omoro District

    Palenga

Other trials in Uganda

About this study

Official title: Reducing HIV-Related Stigma in School Children in Northern Uganda: A Multi-level Arts-Based Population Health Intervention

Over 2.6 million children aged 0-15 years are living with HIV globally, with the majority living in low and middle income countries in sub-Saharan Africa. Addressing stigma associated with HIV is key given the significant harm that may be experienced in the form of negative health and social outcomes, reduced access to HIV prevention services, and increased vulnerability to infection. This stepped-wedge, cluster randomized trial with assess the impact of an arts-based HIV stigma intervention on knowledge and attitudes towards children who are HIV+ and - affected; enacted, internalized, anticipated, courtesy, and perceived stigma (primary outcomes); HIV testing frequency among sexually active participants; linkage to care, antiretroviral therapy (ART) initiation and adherence among HIV+ participants; and viral suppression among HIV+ participants (secondary outcomes) of children aged 10+ years in Omoro District, Uganda, post-intervention and 5-months post-intervention.

Read the detailed description

Background: Over 2.6 million children aged 0-15 years are living with HIV globally, with the majority living in low and middle income countries in sub-Saharan Africa. Addressing stigma associated with HIV is key given the significant harm that may be experienced in the form of negative health and social outcomes, reduced access to HIV prevention services, and increased vulnerability to infection. Previous research among young people in Uganda showed that stigma is meted out in the form of verbal and physical abuse from teachers and peers (bullying), leading to social isolation, school drop-out, depression and suicidal ideation. Given the limited evidence available in support of effective stigma reduction among young people, efforts to help those affected constitute a major gap in the HIV prevention literature.

Purpose: The overall aim of the proposed study is to implement and evaluate an arts-based intervention rooted in local cultural knowledge to reduce stigma and improve HIV prevention outcomes among HIV positive and HIV- affected young people.

Methods: The study will employ a stepped-wedge, cluster randomized design involving crossover of clusters from the control to the intervention arm. The stepped-wedge design will consist of three groups (Group 1, Group 2, Group 3), each comprised of two primary and two secondary schools. Each time period will be 8 weeks in duration. Group 1 will receive the intervention for three time periods (24 weeks). Group 2 will receive the intervention over two time periods (16 weeks). Group 3 will receive the intervention over one time period (8 weeks). Formative qualitative interviews will also inform the arts-based HIV-stigma intervention and obtain additional data for research objectives. We will conduct at 50 qualitative semi-structured interviews, lasting between 30 minutes to 45 minutes, with purposively selected students, Elders, and teachers at participating schools. A community advisory committee (CAC) will inform all design elements and supervise implementation. Team members will collaborate to develop, implement, evaluate and disseminate results of the proposed study. Primary endpoints will include: 1) HIV stigma reduction; and, 2) knowledge increase. Secondary endpoints will include: 1) HIV testing frequency among sexually active participants; 2) linkage to care among HIV+ participants; 3) ART initiation among HIV+ participants; 4) ART adherence among HIV+ participants; and 5) viral suppression among HIV+ participants. Secondary endpoints will be measured through a local AIDS non-governmental organization (TASO) and the community health clinics who have agreed to provide access to their medical files. No blood samples will be drawn. Ages 10+ will participate in the study with parental consent.

Survey Data Analysis: Descriptive analyses will be used to describe clusters relative to their size at each time point (planned sample size and achieved sample size), key demographics and outcomes, and comparison of randomization groups. Main analyses will follow an intention-to-treat approach, with clusters analyzed as per original treatment assignment. Main analyses will use Linear Mixed Effect Models (LMEM) or Generalized Linear Mixed Effect Models (GLMEM) to assess the intervention effect. LMEM will be used for continuous outcomes that approach normality and GLMEM for binary and other types of outcomes. Normality will be assessed by the model residuals and outliers by Cook's Distance, Leverage and Residuals. Calendar time and school semester will be entered as fixed effects. The multilevel structure will be defined by participants as level 1 and clusters as level 2. All clustering levels will be specified as random effects. Sensitivity analyses will be performed of drop-outs and completers to better understand possible biases arising from attrition. A significance level of 0.05 will be used in all statistical tests.

Interview Data Analysis: Interviews will be coded using a constant-comparative and concept-development approach based on emergent themes that evolve throughout the course of the research. Initial coding will be done jointly by two researchers, and consensus negotiated. Matrix methodology techniques described by Miles, Huberman and Saldana will also be used in the analysis. First level analysis will be used to assign a descriptive code (label) to a segment of the data to give it meaning. As the researchers become more familiar with the data, pattern coding will be used to label emerging themes. An inductive approach will be used to analyze the data by iteratively coding and identifying themes and relationships between themes. Memos will be used to record methodological decisions and analytic insights. Validity will be assessed by convening focus groups for member checking the interpretation of data.

Significance: The study it will fill this evidence gap in HIV stigma intervention research and practice by creating and evaluating a transformative education and arts-based intervention using a participatory approach. The method of transforming cultural knowledge to an arts-based intervention may be a reproducible method for locally acceptable intervention design to improve HIV outcomes among young people.

Being tested
Arts-based HIV stigma intervention
Medical subject headings
Health Risk Behaviors, Behavior

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Arts-based HIV stigma interventionBehavioural

    The intervention will consist of 2-hour weekly sessions offered to students in participating schools. HIV-related stigma will be addressed by providing key information related to HIV and stigma, facilitating the acquisition of coping skills, and utilizing local cultural practices facilitated by Elders using creative methods to shift existing social and cultural norms that produce and perpetuate stigmatization. Specific intervention activities will include three interrelated activities. The core 2-hour weekly session will cover (1) transformative educational activities; (2) arts-based activities; (3) a summative activity consisting of (3) participatory theatre activites.

Study groups in NCT04946071
Study groupRoleWhat they receive
ControlNo interventionPeriod in which each group will not receive the arts-based HIV stigma intervention.
Group 1ExperimentalArts-based HIV stigma intervention for three 8-week periods (24 weeks). The intervention will begin with 5 weeks of two 2 interrelated activities: 1) Transformative educational activities that will engage learners in problem-based discussions; 2) Arts-based activities that will focus on addressing the "problem" through finding "solutions" and encouraging action will be accomplished by learning traditional Ugandan songs, dance, told and acted stories, proverbs and sayings that incorporate empowering messages and moral teachings connected with self and community, respect for self, peers and authority, and responsibility for others. These activities will be followed by 3 weeks of a participatory theatre intervention (PTI) developed by students that will summarize the learnings and cultural traditions from the weekly sessions.
Receives: Behavioral: Arts-based HIV stigma intervention
Group 2ExperimentalArts-based HIV stigma intervention for two 8-week periods (16 weeks). Each intervention period will begin with 5 weeks of two 2 interrelated activities: 1) Transformative educational activities that will engage learners in problem-based discussions; 2) Arts-based activities that will focus on addressing the "problem" through finding "solutions" and encouraging action will be accomplished by learning traditional Ugandan songs, dance, told and acted stories, proverbs and sayings that incorporate empowering messages and moral teachings connected with self and community, respect for self, peers and authority, and responsibility for others. These activities will be followed by 3 weeks of a participatory theatre intervention (PTI) developed by students that will summarize the learnings and cultural traditions from the weekly sessions.
Receives: Behavioral: Arts-based HIV stigma intervention
Group 3ExperimentalArts-based HIV stigma intervention for one 8-week period. The intervention period will begin with 5 weeks of two 2 interrelated activities: 1) Transformative educational activities that will engage learners in problem-based discussions; 2) Arts-based activities that will focus on addressing the "problem" through finding "solutions" and encouraging action will be accomplished by learning traditional Ugandan songs, dance, told and acted stories, proverbs and sayings that incorporate empowering messages and moral teachings connected with self and community, respect for self, peers and authority, and responsibility for others. These activities will be followed by 3 weeks of a participatory theatre intervention (PTI) developed by students that will summarize the learnings and cultural traditions from the weekly sessions.
Receives: Behavioral: Arts-based HIV stigma intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change from baseline and between time points in enacted, anticipated and internalized stigma towards HIV+ students

    measured using the Adolescents Living with HIV - Stigma Scale. The scale comprises of 10 items and will be administered by a member of the research team.

    Measured: post-intervention (8 weeks), post-intervention (16 weeks), post-intervention (24 weeks), 5 months post-intervention.

  2. Change from baseline and between time points in courtesy stigma towards HIV+ students

    measured using the Brief Stigma by Association Scale in HIV-affected students. The scale comprises of 10 items and will be administered by a member of the research team.

    Measured: post-intervention (8 weeks), post-intervention (16 weeks), post-intervention (24 weeks), 5 months post-intervention.

  3. Change from baseline and between time points in perceived stigma

    measured using the Stewart's 10-item subscale on felt-normative stigma towards people living with HIV. The scale will be administered by a member of the research team.

    Measured: Baseline (0 weeks), post-intervention (8 weeks), post-intervention (16 weeks), post-intervention (24 weeks), 5 months post-intervention.

  4. Change from baseline and between time points in HIV knowledge

    measured using questionnaire on HIV knowledge. Questionnaire will be administered by a member of the research team.

    Measured: Baseline (0 weeks), post-intervention (8 weeks), post-intervention (16 weeks), post-intervention (24 weeks), 5 months post-intervention.

  5. Change from baseline and between time points for fear of HIV transmission and disease

    measured using questionnaire on fear of HIV transmission and disease. Questionnaire will be administered by a member of the research team.

    Measured: Baseline (0 weeks), post-intervention (8 weeks), post-intervention (16 weeks), post-intervention (24 weeks), 5 months post-intervention.

Secondary outcomes (5)
  1. HIV testing frequency among sexually active participants

    HIV confirmation/diagnosis dates and HIV status. Review of personal health records from community health clinics, and individual medical variables will be crossed-referenced with survey responses, with authorization from the participant (children 13-18 years) and guardian/parent (children 10-12 years).

    Measured: Baseline (0 weeks), post-intervention (8 weeks), post-intervention (16 weeks), post-intervention (24 weeks), 5 months post-intervention.

  2. Initiation of linkage to care among HIV+ participants

    Initiation of linkage to care (yes/no) through review of personal health records from community health clinics and individual medical variables will be crossed-referenced with survey responses, with authorization from the participant and guardian/parent.

    Measured: Baseline (0 weeks), post-intervention (8 weeks), post-intervention (16 weeks), post-intervention (24 weeks), 5 months post-intervention.

  3. ART initiation among HIV+ participants

    Initiation of ART initiation (yes/no) through review of personal health records from community health clinics and individual medical variables will be crossed-referenced with survey responses, with authorization from the participant and guardian/parent.

    Measured: Baseline (0 weeks), post-intervention (8 weeks), post-intervention (16 weeks), post-intervention (24 weeks), 5 months post-intervention.

  4. Change from baseline and between time points in viral suppression among HIV+ participants

    copies/ml, through review of personal health records from community health clinics with authorization from the participant and guardian/parent.

    Measured: post-intervention (8 weeks), post-intervention (16 weeks), post-intervention (24 weeks), 5 months post-intervention.

  5. Change from baseline and between time points in ART adherence

    capsules taken/capsules prescribed, through review of personal health records from community health clinics and individual medical variables will be crossed-referenced with survey responses, with authorization from the participant and guardian/parent.

    Measured: post-intervention (8 weeks), post-intervention (16 weeks), post-intervention (24 weeks), 5 months post-intervention.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Jun 2021
  2. Study start5 May 2021
  3. Primary completion24 Nov 2023
  4. Study completion6 Jan 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Crossover
Model description
The study will employ a stepped-wedge, cluster randomized design involving crossover of clusters from the control to the intervention arm.
Masking
None (open label)
Enrolment
2,900 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04946071
Sponsor's protocol ID
102240
Status last verified
Nov 2024
First submitted
28 May 2021
Last updated
22 Nov 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Mendelsohn JB, Fournier B, Caron-Roy S, Maina G, Strudwick G, Ojok S, Lim HJ, Sanches M, Logie CH, Sommerfeldt S, Nykiforuk C, Harrowing J, Adyanga FA, Hakiigaba JO, Bilash O. Reducing HIV-related stigma among young people attending school in Northern Uganda: study protocol for a participatory arts-based population health intervention and stepped-wedge cluster-randomized trial. Trials. 2022 Dec 23;23(1):1043. doi: 10.1186/s13063-022-06643-9.

    PubMed 36564802

Questions about this trial

What is this clinical trial studying?

A study testing Arts-based HIV stigma intervention in people with HIV-related Stigma and Health Risk Behaviors, run by Thompson Rivers University at 1 site in Uganda.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Nov 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Uganda. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change from baseline and between time points in enacted, anticipated and internalized stigma towards HIV+ students (time frame: post-intervention (8 weeks), post-intervention (16 weeks), post-intervention (24 weeks), 5 months post-intervention.). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04946071, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Nov 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in